Mon, April 4, 2011
[ Mon, Apr 04th 2011 ]: Market Wire
Abiomed Announces Schedule of Events at American College of Cardiology 2011 Scientific Conference
[ Mon, Apr 04th 2011 ]: Market Wire
Abiomed Announces Final PROTECT II Study Results .. ulation at American College of Cardiology 2011 Sc
[ Mon, Apr 04th 2011 ]: Market Wire
ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkina?s Lymphoma
Sun, April 3, 2011
[ Sun, Apr 03rd 2011 ]: Market Wire
Antrim Energy and Partners to Drill East Fyne Well, UK North Sea
[ Sun, Apr 03rd 2011 ]: Market Wire
Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
[ Sun, Apr 03rd 2011 ]: Market Wire
Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC
[ Sun, Apr 03rd 2011 ]: Market Wire
Edwards Lifesciences Achieves Primary Endpoint in .. theter Valve Study of High-Risk Surgical Patients
Sat, April 2, 2011
[ Sat, Apr 02nd 2011 ]: Market Wire
Orthofix Appoints Vicente Trelles as Senior Vice .. sident, World Wide Operations and Shared Services
[ Sat, Apr 02nd 2011 ]: Market Wire
Investigational Compound PEG-Interferon Lambda Ac .. with Fewer Flu-Like and Musculoskeletal Symptoms
[ Sat, Apr 02nd 2011 ]: Market Wire
Medtronic Announces FDA Approval of InterStim® Therapy for Bowel Control
[ Sat, Apr 02nd 2011 ]: Market Wire
MEDNAX 2011 First Quarter Conference Call/Webcast Scheduled for Tuesday May 3, 2011
Fri, April 1, 2011
[ Fri, Apr 01st 2011 ]: Market Wire
AdCare Health Systems Closes $2.1 Million Convert .. nt and Secures $1.4 Million Bridge Loan Financing
[ Fri, Apr 01st 2011 ]: Market Wire
MedMira Announces Second Quarter Results
[ Fri, Apr 01st 2011 ]: Market Wire
LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM MARKET VALUE OF LISTED SECURITIES
[ Fri, Apr 01st 2011 ]: Market Wire
PromiusTM Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
[ Fri, Apr 01st 2011 ]: Market Wire
ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan, Inc.
[ Fri, Apr 01st 2011 ]: Market Wire
Data on IPX066 APEX-PD Phase III Study for the Tr .. s Disease to be Presented at the American Academy
[ Fri, Apr 01st 2011 ]: Market Wire
Aethlon Medical Discloses Part II of Emerging Opportunities in Biodefense Interview
[ Fri, Apr 01st 2011 ]: Market Wire
St Eugene Commences 2011 Exploration Program at Tartan Lake Mine Project
[ Fri, Apr 01st 2011 ]: Market Wire
Equity Research on Aetna Inc. and Unitedhealth Gr .. nc. - Health Care Providers Positioned for Growth
[ Fri, Apr 01st 2011 ]: Market Wire
Equity Research on Medtronic Inc. and St. Jude Me .. , Implantable Defibrillators Pumping Up Medical A
[ Fri, Apr 01st 2011 ]: Market Wire
AVI BioPharma Prices $30.0 Million Public Offering of Common Stock
[ Fri, Apr 01st 2011 ]: Market Wire
Liberty Metals & Mining Exercises Participation R .. Million IFC Financing for Further Proceeds of Up
[ Fri, Apr 01st 2011 ]: Market Wire
MEDNAX Announces the Acquisition of Practices in San Antonio, TX and Miami, FL
Thu, March 31, 2011
[ Thu, Mar 31st 2011 ]: Market Wire
A CIGNA bel©pett a globlis egy©ni eg©szs©gbiz .. zette a CIGNA Globlis Eg©szs©gbiztostsi Opcikat
[ Thu, Mar 31st 2011 ]: Market Wire
PROTOX REPORTS 2010 FINANCIAL RESULTS AND ACHIEVEMENTS
[ Thu, Mar 31st 2011 ]: Market Wire
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
[ Thu, Mar 31st 2011 ]: Market Wire
RXi Pharmaceuticals Aggressively Moves into Late- .. pment with the Agreement to Acquire Apthera, Inc.
[ Thu, Mar 31st 2011 ]: Market Wire
AVEO Pharmaceuticals, Inc. to Present at the Leerink Swann Cancer Roundtable Conference
[ Thu, Mar 31st 2011 ]: Market Wire
Interim Phase 2 Data Showed Rapid Viral Response .. Telaprevir, Pegylated-Interferon and Ribavirin A
[ Thu, Mar 31st 2011 ]: Market Wire
SuperGen PIM Kinase Presentations at AACR
[ Thu, Mar 31st 2011 ]: Market Wire
SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011
[ Thu, Mar 31st 2011 ]: Market Wire
A.P. Pharma Announces Transfer to OTCQB
[ Thu, Mar 31st 2011 ]: Market Wire
Inhibitex Reports Positive Safety and Antiviral D .. hase 1b Study of HCV Nucleotide Inhibitor INX-189
[ Thu, Mar 31st 2011 ]: Market Wire
Inhibitex Announces Data Presentation at the 46th .. ean Association for the Study of the Liver (EASL)
[ Thu, Mar 31st 2011 ]: Market Wire
The New England Journal of Medicine Publishes Stu .. ational Medicine VICTRELISa" (boceprevir) in Comb
Wed, March 30, 2011
[ Wed, Mar 30th 2011 ]: Market Wire
Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results
[ Wed, Mar 30th 2011 ]: Market Wire
Dyax Corp. to Present at the Needham & Company Healthcare Conference
[ Wed, Mar 30th 2011 ]: Market Wire
CIGNA betritt Privatkundensegment mit neuer Krankenversicherung CIGNA Global Health Options
[ Wed, Mar 30th 2011 ]: Market Wire
ImmunoGen, Inc. Announces Presentations at the 10 .. g of the American Association for Cancer Research
[ Wed, Mar 30th 2011 ]: Market Wire
Alnylam to Webcast Presentation at 10th Annual Needham Healthcare Conference
[ Wed, Mar 30th 2011 ]: Market Wire
CIGNA entra nel mercato sanitario globale per le persone lanciando CIGNA Global Health Options
[ Wed, Mar 30th 2011 ]: Market Wire
CIGNA entra no mercado de atendimento m©dico individual; lanamento do CIGNA Global Health Options
[ Wed, Mar 30th 2011 ]: Market Wire
Mendacious Articles Against Radient Pharmaceuticals Taking Toll on Tabloid's Credibility
[ Wed, Mar 30th 2011 ]: Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Cardio
[ Wed, Mar 30th 2011 ]: Market Wire
Antrim Energy Inc. Announces the Filing of Its National Instrument 51-101 Reports
[ Wed, Mar 30th 2011 ]: Market Wire
Baby, It's Cold Outside, But Pharmaceutical Industry Is Hot, an Industrial Info News Alert
[ Wed, Mar 30th 2011 ]: Market Wire
Bernstein Liebhard LLP Announces Investigation of Offer for Cephalon, Inc.

Biogen Idec y Knopp Biosciences anuncian la participacin del primer paciente en un estudio mundial de fase III de Dexpramipexol

WESTON, Mass. & PITTSBURGH--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) y [ Knopp Biosciences ] han anunciado la participacin del primer paciente en EMPOWER, un estudio de fase III multinacional que evala la eficacia, seguridad y farmacocin©tica de dexpramipexole en pacientes con esclerosis lateral amiotrfica (ALS en sus siglas en ingl©s). ALS, tambi©n conocida como enfermedad de Lou Gehrig y enfermedad de la neurona motora (MND en sus siglas en ingl©s), es una enfermedad degenerativa y que progresa con rapidez de las neuronas motoras del cerebro y la m©dula espinal.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.